Mackay Shields LLC reduced its holdings in shares of HMS Holdings Corp (NASDAQ:HMSY) by 13.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 133,559 shares of the business services provider’s stock after selling 20,700 shares during the period. Mackay Shields LLC owned about 0.15% of HMS worth $4,603,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. lifted its stake in shares of HMS by 5.9% during the 2nd quarter. BlackRock Inc. now owns 13,324,234 shares of the business services provider’s stock worth $431,572,000 after acquiring an additional 737,668 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of HMS by 4.6% during the 2nd quarter. Vanguard Group Inc. now owns 9,212,609 shares of the business services provider’s stock worth $298,396,000 after acquiring an additional 406,208 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of HMS by 0.5% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 2,629,880 shares of the business services provider’s stock worth $85,182,000 after acquiring an additional 14,227 shares during the last quarter. Stephens Investment Management Group LLC lifted its stake in shares of HMS by 0.6% during the 2nd quarter. Stephens Investment Management Group LLC now owns 1,479,955 shares of the business services provider’s stock worth $47,936,000 after acquiring an additional 8,269 shares during the last quarter. Finally, Nuveen Asset Management LLC bought a new stake in shares of HMS during the 2nd quarter worth approximately $46,427,000. 96.50% of the stock is owned by hedge funds and other institutional investors.
A number of equities research analysts recently issued reports on HMSY shares. Guggenheim lowered HMS from a “buy” rating to a “neutral” rating and set a $43.00 price target for the company. in a research note on Thursday, August 22nd. Credit Suisse Group reduced their price objective on HMS from $45.00 to $34.00 and set an “outperform” rating on the stock in a report on Monday, November 4th. Leerink Swann assumed coverage on HMS in a report on Monday, August 5th. They set an “outperform” rating and a $50.00 price objective on the stock. Svb Leerink restated an “outperform” rating and set a $50.00 price objective on shares of HMS in a report on Monday, August 5th. Finally, ValuEngine downgraded HMS from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $40.76.
HMSY traded up $0.39 during trading on Friday, hitting $27.17. 590,200 shares of the stock were exchanged, compared to its average volume of 580,870. The firm has a 50 day simple moving average of $33.14 and a 200 day simple moving average of $33.52. HMS Holdings Corp has a 1 year low of $24.43 and a 1 year high of $40.67. The company has a debt-to-equity ratio of 0.31, a quick ratio of 6.72 and a current ratio of 6.68. The firm has a market cap of $2.37 billion, a price-to-earnings ratio of 32.35, a P/E/G ratio of 2.31 and a beta of 1.16.
HMS (NASDAQ:HMSY) last issued its quarterly earnings results on Friday, November 1st. The business services provider reported $0.30 EPS for the quarter, topping the Zacks’ consensus estimate of $0.28 by $0.02. The company had revenue of $146.82 million during the quarter, compared to analysts’ expectations of $165.79 million. HMS had a return on equity of 14.28% and a net margin of 16.69%. The firm’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.28 EPS. As a group, equities analysts anticipate that HMS Holdings Corp will post 1.06 earnings per share for the current fiscal year.
In other news, CEO William C. Lucia sold 32,005 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $37.06, for a total value of $1,186,105.30. Following the completion of the transaction, the chief executive officer now owns 172,378 shares of the company’s stock, valued at approximately $6,388,328.68. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Jeffrey Scott Sherman sold 35,896 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $38.83, for a total value of $1,393,841.68. Following the completion of the transaction, the chief financial officer now directly owns 213,661 shares of the company’s stock, valued at approximately $8,296,456.63. The disclosure for this sale can be found here. In the last three months, insiders sold 220,656 shares of company stock valued at $8,376,626. Insiders own 2.87% of the company’s stock.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.
Further Reading: Marijuana Stocks Investing Considerations
Want to see what other hedge funds are holding HMSY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HMS Holdings Corp (NASDAQ:HMSY).
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.